Anavex Life Sciences Corp (AVXL)

[found_it2]

"Invesco Ltd. Grows Stake in Anavex Life Sciences Corp."

MarketBeat April 28, 2025
Invesco Ltd. raised its stake in shares of Anavex Life Sciences Corp.by 2,419.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission.
The fund owned 615,048 shares of the biotechnology company's stock after purchasing an additional 590,639 shares during the period. Invesco Ltd. owned 0.73% of Anavex Life Sciences worth $6,606,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AVXL:

- ADAR1 Capital Management LLC bought a new position in shares of Anavex Life Sciences during the fourth quarter worth about $174,000.
- Envestnet Asset Management Inc. lifted its position in shares of Anavex Life Sciences by 54.2% in the 4th quarter. Envestnet Asset Management Inc. now owns 59,066 shares of the biotechnology company's stock worth $634,000 after purchasing an additional 20,771 shares during the period.
- Trexquant Investment LP increased its position in shares of Anavex Life Sciences by 26.8% during the fourth quarter. Trexquant Investment LP now owns 71,474 shares of the biotechnology company's stock worth $768,000 after buying an additional 15,109 shares during the period.
- Alliancebernstein L.P. raised its stake in Anavex Life Sciences by 6.8% during the fourth quarter. Alliancebernstein L.P. now owns 115,200 shares of the biotechnology company's stock worth $1,237,000 after buying an additional 7,360 shares during the last quarter.
- Finally, Wellington Management Group LLP acquired a new position in Anavex Life Sciences in the fourth quarter valued at $1,704,000.
31.55% of the stock is owned by institutional investors and hedge funds.